Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 14 (MTND5P14) is a nuclear-encoded pseudogene, meaning it is a genomic sequence similar to the functional MT-ND5 gene but lacks the ability to produce a functional protein. MTND5P14 is not transcribed into a protein and does not participate in biological pathways or therapeutic mechanisms. Functional MT-ND5 (not the pseudogene) encodes a subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase) essential for oxidative phosphorylation, but the pseudogene forms, including MTND5P14, are considered non-functional and do not contribute to cellular bioenergetics or disease phenotypes. In human reference genome GRCh38, MTND5P14 is located on chromosome 9. There is no evidence for its involvement in disease or use as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 14 (MTND5P14).